8-K ·Filed May 13, 2026

IRWD

IRONWOOD PHARMACEUTICALS INC
MIXED
Impact 6/10
Horizonweeks Processed4mo ago SEC0001104659-26-059814
8-K context-dependent: Items 5.02
Actionable Insight ◆ Mixed

Monitor for permanent CFO appointment and outcome of June 16, 2026 annual meeting proxy contest. The leadership change amid governance uncertainty could pressure the stock near-term.

DirectionMixed
Confidencehigh
Horizonweeks
Final — all horizons settled through T+60d
IRWD ▲ +17.39% at T+60d
NEUTRAL call ✓ call won +17.39% · α vs SPY +12.95% · entry $3.68 → $4.32
Entry anchored
May 12, 03:59 PM ET
via exchange tick
T+1d
-0.27%
call -0.27% · α -1.05%
$3.67
settled 5mo ago
T+5d
-0.27%
call -0.27% · α +0.89%
$3.67
settled 5mo ago
T+20d
-1.36%
call -1.36% · α -0.75%
$3.63
settled 4mo ago
T+60d
+17.39%
call +17.39% · α +12.95%
$4.32
settled 8w ago

Price Chart

Loading chart...

Executive Summary

IRWD CFO Gregory Martini resigned effective May 15, 2026, with Ronald Silver serving as interim CFO. The resignation is not due to financial reporting disagreements, but comes 15 days after a DEFA14A proxy filing indicating a contested board election. The combination of CFO departure and ongoing proxy fight elevates uncertainty around leadership and governance.

Key Facts

  • CFO Gregory Martini resigned effective May 15, 2026
  • Resignation not due to disagreement on financial reporting
  • Ronald Silver, SVP Corporate Controller & CAO, appointed interim CFO
  • DEFA14A filed April 28, 2026 signals contested proxy election
  • No permanent CFO replacement announced

Financial Impact

Not specified

Risk Factors

  • Prolonged CFO vacancy or difficulty attracting permanent CFO
  • Proxy contest outcome may lead to board overhaul and strategic shifts
  • Potential for additional executive departures

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
70% bullish (10 analysts)

Investment Themes

Biotech & Drug Discovery

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001104659-26-059814
Document: 0001104659-26-059814-index-headers.html0001104659-26-059814
Document: 0001104659-26-059814-index.html0001104659-26-059814
Document: 0001104659-26-059814.txt0001104659-26-059814
6 reports for IRWD
Performance horizon
100% Hit rate 5 of 5 directional calls best @ T+20▲ +12.27%Feb 23, 2026
Filters
Rows
Reports for IRWD — sortable, filterable
TypeNow
Aug 6, 2026
8w ago
8-K
BULLISH ★ 7/10
$4.26 $4.29▲ +0.70%▲ +0.10%$3.62 (−15.02%)
May 13, 2026
20w ago
8-K
MIXED ★ 6/10
$3.68 $3.63▼ −1.36%▼ −0.75%$3.62 (−1.63%)
May 7, 2026
21w ago
8-K
BULLISH ★ 7/10
$4.17 $3.24▼ −22.30%▼ −25.44%$3.62 (−13.19%)
Feb 25, 2026
31w ago
8-K
BEARISH ★ 5/10
$3.36 $3.19▲ +5.06%▼ −0.18%$3.62 (−7.74%)
Feb 23, 2026
31w ago
Insider Cluster
BEARISH ★ 6/10
$3.75 $3.29▲ +12.27%▲ +8.32%$3.62 (+3.47%)
Feb 23, 2026
31w ago
Insider Cluster
BEARISH ★ 7/10
$3.75 $3.29▲ +12.27%▲ +8.32%$3.62 (+3.47%)
Showing 6 of 6

US Market Status

Market Open — Closes in 48m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access